CS Paper Radar

Coupled Graph--Policy Distillation for Personalized Medication Safety in Older Adults with Multimorbidity

Zihan Wang, Anglin Liu, Rongyi Wang, Dantong Li, Yi Lu, Siqing Yuan, Hongxia Xu, Zhongtian Long, Jintai Chen

cs.AI ·submitted 2026-08-10 11:19 UTC · v1
benchmark

Abstract

Large language model (LLM) agents can support medication review between clinical visits, but safe choices for older adults with multimorbidity depend on conditions, medications, and geriatric risks that users may omit. We introduce ATLAS, a coupled graph--policy distillation framework for patient-adaptive medication safety. ATLAS structures guideline evidence as a medication-safety graph. Targeted questions update the patient state and distill relevant relations into a patient-specific medication conflict graph (PMCG). A risk-first multi-agent policy uses the PMCG to screen contraindications, assess cautions and monitoring needs, identify safer alternatives, and verify the final medication plan. We also introduce GeriMedBench, an interactive benchmark that tests safety-critical information acquisition and evidence-based decision revision. Across a European non-interactive multimorbidity benchmark, an Asian interactive multimorbidity benchmark, and an Asian non-interactive cross-guideline benchmark, ATLAS achieves the strongest complete-decision performance among the compared systems. On the European non-interactive multimorbidity benchmark, it exceeds the strongest proprietary LLM baseline by 53.73 points in Strict Success Rate and 14.63 points in overall safety reasoning score (OSRS), with no unsafe recommendations under the automated evaluator. A blinded clinician evaluation gives ATLAS higher mean ratings across all five criteria and flags potentially unsafe recommendations in one ATLAS case and two Gemini cases.

Closest papers

Nearest neighbours by meaning across the whole index.

PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making

cs.CL cs.AI ·2026-10-14 ·Ziyang Ling, Shuyu Lu, Ziyi Chen
hot direction similarity 0.69
Abstract

Medical prescribing errors for multimorbid patients, who require complex drug regimens, are a major patient safety concern. These errors often stem from fragmented decision-making across medical specialties, a critical coordination failure that leads to adverse drug events and rehospitalizations. To address this coordination challenge, we introduce PRISMATIC, a multi-agent architecture where specialized agents, each representing a workflow role, collaboratively generate and refine treatment plans. Operating on a blackboard architecture, the system first structures patient information from clinical notes, then iteratively develops safe, rational, and interpretable drug regimens. The agents' collaboration is governed by two novel adaptive coordination mechanisms: (1) Dynamic Self-Updating Weight Adjustment (DSWA), a long-term mechanism that adjusts the influence weights of agents based on historical case outcomes, enabling the system to adapt and trust more reliable specialists over time. (2) Discrepancy Feedback Precise Calibration (DFPC), a short-term mechanism where agents provide iterative feedback to resolve disagreements and eliminate prescription conflicts for the current patient. Experiments on patient records from the MIMIC-IV database show that PRISMATIC significantly reduces drug conflicts, improves prescription coverage, and enhances treatment consistency compared to strong LLM baselines. Our work demonstrates that structuring clinical co-treatment as a multi-agent coordination problem offers a promising path toward safer and more coherent multidisease management.

0.29

RES-MR: Risk-Aware Reasoning for Explainable and Safe Medication Recommendation

cs.LG cs.AIcs.IR ·2026-10-10 ·Cong Wang, Jin Li, Shoujin Wang, Yishuo Li, Huilin Gu +1 more
top venuebenchmarkcode/datahighly cited similarity 0.69
Abstract · 12 pages

Medication recommendations seek to deliver personalized drug combinations based on patients' clinical information, where ensuring transparent decision-making and personalized safety are of paramount importance. However, existing approaches predominantly operate as ``black boxes'', offering limited interpretability and hindering clinician trust. Furthermore, they typically rely on fixed, patient-agnostic safety constraints, neglecting the heterogeneity of risk tolerance across individuals, which poses significant risks to vulnerable populations. To address these gaps, we propose \textbf{RES-MR}, a novel Risk-aware Reasoning framework for Explainable and Safe Medication Recommendation using LLMs. RES-MR follows a two-stage training paradigm: (1) an explainable clinical reasoning distillation stage to elicit diagnostic capabilities by fine-tuning on synthesized reasoning trajectories, grounded in patient-specific knowledge from graph retrieval; and (2) a risk-aware policy optimization stage to dynamically balance therapeutic efficacy with personalized safety. This stage employs disentangled drug factors to construct patient-specific reference prototypes that capture desired therapeutic drug features and risk features to avoid. These prototypes enable risk boundary calibration and guide the model toward safe recommendations via reward shaping and clipping. Extensive experiments on benchmark datasets demonstrate that RES-MR significantly outperforms state-of-the-art baselines in terms of accuracy, safety, and explainability. Our code and data are available at: https://github.com/wangcong2001/RES-MR.

0.78

Evidence, Logic, and Compliance: Multi-Agent Structured Graph Reasoning with Expert Arbitration for Medical Referral

cs.MA ·2026-08-31 ·Qi Peng, Yi Cai, Jialin Cui, Tong Zhu, Yujuan Ding +5 more
similarity 0.67
Abstract · 18 pages

Medical referral (directing patients to the appropriate hospital department) is a complex decision-making process requiring the synthesis of multimodal data, including patient narratives, laboratory indicators, and radiology imaging. While Large Language Models (LLMs) have advanced medical dialogue systems, they struggle with real-world referral tasks due to two primary limitations: (1) Information Overload, where models fixate on high-frequency disease terms while overlooking subtle but critical urgency indicators; and (2) Unstructured Collaboration, where existing multi-agent frameworks rely on loose dialogue that leads to semantic drift and confirmation bias. To address these challenges, we introduce MASGR (Multi-Agent Structured Graph Reasoning), a framework that treats referral not as a classification task but as a structured graph construction problem. MASGR deploys specialized agents to extract evidence from distinct modalities and coordinates them through a clinical reasoning graph. This graph forces agents to establish explicit logical connections between conflicting evidence. Furthermore, we integrate a knowledge-guided arbitration mechanism that prioritizes patient safety rules over standard diagnostic classification. Extensive experiments on real-world medical records demonstrate that MASGR significantly outperforms state-of-the-art LLMs and existing multi-agent systems, particularly in complex cases requiring the balancing of chronic disease management and emergency intervention. The AI contribution lies in the Multi-Agent Structured Graph Reasoning framework that transforms unstructured multi-agent dialogue into a verifiable logical graph construction. The engineering application is demonstrated through its deployment in a complex healthcare decision-making system to optimize the precision of complex medical referrals.

0.17

HEM-Med: A Hierarchical Agentic Memory Framework for Safe Multi-Center Medication Recommendation

cs.AI cs.IR ·2026-10-14 ·Min Xiao, Jin Li, Shoujin Wang, Yeguang Zhen, Yishuo Li +1 more
similarity 0.67
Abstract · BIBM 2026

Medication recommendation (MR) is critical for clinical decision support. While existing MR methods are mostly designed for single-center learning, where only one independent hospital is involved, multi-center MR with hospitals of different scales has become increasingly demanding in practice. In multi center settings, abundant data from large medical centers can improve recommendation performance for low-resource centers. Despite a few preliminary attempts on this task, two critical gaps remain. Gap 1: Existing multi-center methods fail to disentangle transferable cross-hospital clinical experience from hospital-specific prescribing patterns, limiting clinical feasibility and physician acceptance. Gap 2: They commonly overlook multi label safety constraints of MR, including drug-drug interaction risks and local formulary feasibility, which are essential for safe real-world deployment. To address these gaps, we propose HEM-Med, a novel hierarchical agentic memory framework for multi-center MR. To address Gap 1, we design a disentangled hierarchical memory module that builds patient-level medication context attribution records and disentangles them into cross hospital experience memory and hospital-specific residual memory. To address Gap 2, we introduce a safety-aware medication set generation module, which integrates dual-level experience retrieval with safety-aware set decoding to produce clinically relevant, safer, and locally adaptive medication recommendations. Experiments on a real-world multi-center eICU dataset show that HEM-Med outperforms representative transfer learning, LLM-based, and MR baselines in terms of both recommendation accuracy and safety.

0.07

Feedback-Robust AI for Patient Knowledge Graphs

cs.LG ·2026-09-27 ·Mohammed Sameer Syed
similarity 0.63
Abstract · 66 pages, 4 figures

Patient knowledge graphs from bedside monitoring should type their relations and state whether the data support their signs. In anesthesia and intensive care, clinicians titrate drugs and ventilation in response to the physiology, so temporal relations mix the patient's response with the clinician's policy. We introduce ClosedLoopBench: 29 relations with signs fixed by physics, pharmacology or clinical practice, on 3,442 VitalDB surgical cases (12,653 h) with negative-control action streams. When each patient's actions are replaced by another patient's, six of 12 estimators declare on average 11-18 of their 19-29 distinct relation estimates significant without calibration, and after calibration cross-correlation and Granger tests still assign ventilator rate -> end-tidal CO2 the sign of the clinician's policy. We propose feedback-robust patient graphs that combine concept nodes with evidence pointers, typed relations admitted against negative controls, and beat-level couplings. On VitalDB under null streams, our graphs contain 0.06-0.10 false concept-level relation instances per graph, versus 10-12 for correlational construction. Patient-specific estimates of 11 slow drug and ventilator responses predict later data no better than population estimates, whereas the pulse-arrival-time-systolic-pressure slope is negative in 94.3% of 2,884 cases and patient-specific (early-late correlation 0.67 [0.63, 0.70]).

0.20

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

cs.AI ·2026-11-17 ·Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko +8 more
similarity 0.63
Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

0.29

Clinical Graph-JEPA: Predictive Patient-State Knowledge Graphs for Cognitive Decision Support

cs.LG cs.AI ·2026-08-23 ·Kushagra Yadav, Nalin Prabhath, Amit Lamba, James E. Schrager, Goeun Han +1 more
published similarity 0.62
Abstract · Accepted at WM@Booth 2026

Clinical records contain rich evidence about patient state, but converting that evidence into reliable, structured knowledge graphs remains difficult because extraction errors, ontology mismatch, missing relations, and temporal ambiguity can propagate into downstream systems. We propose a clinical knowledge graph construction and refinement framework that combines multi-agent relation proposal, ontology-aware normalization, deterministic evidence scoring, and JEPA-based latent refinement. Rather than treating a clinical knowledge graph as a static extraction artifact, we treat it as a predictive patient-state representation. For each admission, the system constructs an evidence-scored graph from structured MIMIC-IV records and inferred clinical cross-links, then learns to recover held-out clinical relations from the observed graph context. We evaluate the refiner with leakage-free leave-one-out edge recovery (MRR and Hits@k) and held-out batch-mask evaluation (AUC and MRR). To isolate the contribution of discharge-note context, we compare a note-embedding-free configuration with a note-augmented configuration that injects real discharge-note representations only into note-grounded entities. Under the same cohort and evaluation protocol, entity-grounded note injection improves overall leave-one-out MRR by 31% relative improvement.

0.31

CareGraph: An Auditable Hybrid AI Framework for Evidence-Grounded Personalized Longitudinal Health Intelligence

cs.AI cs.IRcs.MA ·2026-08-25 ·Pratik Ghawate, Tanvi Patil
benchmarkcode/data similarity 0.62
Abstract · 21 pages, 7 figures, Code and data: https://github.com/PratikGhawate/ai-personalized-health-intelligence

Artificial intelligence is transforming personalized healthcare, yet fragmented clinical, self reported, and wearable evidence remains difficult to interpret and trace. We present CareGraph, an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations. CareGraph organizes evidence without diagnosing, predicting outcomes, selecting treatment, or making autonomous clinical decisions. Its pipeline covers deterministic analysis, context detection, graph construction, constrained language model synthesis, evidence validation, safety controls, and release gating. Tests used synthetic cohorts of 400 patients each for development, validation, and holdout. On holdout data, a frozen ordinary least squares trend rule with a sufficiency gate achieved 0.827 accuracy, 0.837 macro F1 with a 95 percent confidence interval of 0.819 to 0.854, and 0.974 insufficient data F1. Missing context detection achieved 0.815 strict micro F1 versus 0.318 for the legacy detector. On an authored holdout benchmark, safety ruleset version 1.2 achieved 1.000 precision, 0.950 recall, and 0.974 F1. An audit requiring graph retrieval across 80 patients yielded 79 syntheses and 78 presentations without fallback; one output was blocked and one failed closed because of an invalid evidence key. Against monolithic GPT 5.6 on 56 matched patients, CareGraph was faster at 40.15 versus 49.62 seconds, shorter at 661 versus 1,163 words, and showed better exploratory lexical alignment with longitudinal targets; the baseline used fewer tokens and cited more raw evidence. Graph auditing verified provenance and deterministic retrieval; incremental graph effects on generation require paired evaluation. CareGraph offers a safety bounded foundation for intelligent personalized health systems.

0.42